<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02068118</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A01672-41</org_study_id>
    <nct_id>NCT02068118</nct_id>
  </id_info>
  <brief_title>Optimization of the Ambulatory Monitoring for Patients With Heart Failure by Tele-cardiology</brief_title>
  <acronym>OSICAT</acronym>
  <official_title>Optimisation de la Surveillance Ambulatoire Des Insuffisants CArdiaques Par Télécardiologie (OSICAT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CDM e-Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CDM e-Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Targeted population: Patients with heart failure causing hospitalization during the last&#xD;
      twelve months.&#xD;
&#xD;
      Hypothesis: The number of all cause deaths and hospitalizations will be smaller for the&#xD;
      Telecardiology group than for the reference group (standard follow-up care). An 18 months&#xD;
      period of observation is required.&#xD;
&#xD;
      Main goal: To compare the rate of all cause deaths and hospitalizations of patients with&#xD;
      heart failure between the Telecardiology group and the reference group after 18 months of&#xD;
      monitoring.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COMPARATIVE STUDY:&#xD;
&#xD;
      Comparative study of patients with chronic heart failure, randomized ratio (1:1), with two&#xD;
      study arms (telecardiology vs usual care). French multicenter study.&#xD;
&#xD;
      The planned enrolment is 990 patients in a total period of 3.5 years. This study will involve&#xD;
      an enrolment visit, managed by the recruiting investigator cardiologist, then four telephone&#xD;
      contacts by Clinical Studies Technicians (CST). The purpose of the CST telephone contacts is&#xD;
      to record the study data, and this will be occur for both study arms. Throughout the study,&#xD;
      the patients in the telecardiology study arm will have regular contact with the Cordiva&#xD;
      nurses for the management of their chronic heart failure, through telemonitoring and&#xD;
      coaching. There is no planned hospitalization for the study.&#xD;
&#xD;
      Patients in the control group will receive the usual care: After enrolment, they will return&#xD;
      home and will subsequently have regular visits to their General Practitioner (GP) or&#xD;
      referring cardiologist.&#xD;
&#xD;
      Patients in the telecardiology group will receive the necessary monitoring equipment in their&#xD;
      home in the week following their enrolment visit. This equipment includes a connected&#xD;
      electronic scale and a questionnaire box. This questionnaire is designed to evaluate the&#xD;
      evolution of patient symptoms.&#xD;
&#xD;
      During the presentation of the study to the patient before study inclusion, the investigator&#xD;
      will inform the patient about the use of the equipment.&#xD;
&#xD;
      The material provided is &quot;self installable&quot; but if the patient asks for help, the equipment&#xD;
      will be installed at the patient's home by a private nurse, who also will check that the&#xD;
      patient knows how to use the equipment.&#xD;
&#xD;
      Each patient will respond daily to 8 yes/no questions:&#xD;
&#xD;
        -  Did you have more breathing issues last night than the previous night?&#xD;
&#xD;
        -  Did you need an extra pillow for better breathing last night?&#xD;
&#xD;
        -  Do you cough more than usual?&#xD;
&#xD;
        -  Are your legs are more swollen than usual?&#xD;
&#xD;
        -  Do you feel yourself more tired than usual?&#xD;
&#xD;
        -  Have you had or do you have a fever above 38.5 °C?&#xD;
&#xD;
        -  Have you felt or do you feel palpitations?&#xD;
&#xD;
        -  Do you find that your physical activity is more limited today than the previous days?&#xD;
&#xD;
      Patients should simply answer yes or no to all of these questions through the questionnaire&#xD;
      box.&#xD;
&#xD;
      The self-monitoring parameters (weight and questionnaire answers) will be remotely&#xD;
      transmitted via standard phone lines (wired, 3G or GPRS) to the secured servers.&#xD;
&#xD;
      These data will be analyzed automatically by an expert system that will generate an alert in&#xD;
      case of abnormal values. The objective is to anticipate possible acute cardiac failure.&#xD;
&#xD;
      The specialized nurses from the Cordiva center will manage those alerts during working hours&#xD;
      and will contact the patient to validate with him the relevance of the alert. If the clinical&#xD;
      reality of the alert is confirmed, the nurse will advise the patient to contact his GP or&#xD;
      referring cardiologist. In parallel to the nurse advising the patient, the referring&#xD;
      physician will receive an alert report including the weight values and the symptoms which&#xD;
      triggered this alert. Then, he can then take any action he considers appropriate.&#xD;
&#xD;
      A binder will be sent to the patients. This will contain various information related to the&#xD;
      management of their heart failure: heart physiology, symptoms, treatments, diet, physical&#xD;
      activity...&#xD;
&#xD;
      The purpose of this binder is to support the discussion between the Cordiva nurses and the&#xD;
      patient.&#xD;
&#xD;
      Upon receipt and installation of the equipment in the patient's home, the nurses will arrange&#xD;
      a first telephone interview, which will last approximately 45 minutes. The nurses will first&#xD;
      introduce the team and the overall clinical approach, and will have a discussion with the&#xD;
      patient to better understand the patient (anamnesis, treatment, psycho-social profile,&#xD;
      smoking, alcohol use, physical activity, and so on).&#xD;
&#xD;
      After this call, patient and nurse will together determine together the date for the next&#xD;
      phone call date.&#xD;
&#xD;
      On a regular basis (for example every three weeks), a Cordiva nurse will call the patient to&#xD;
      check the current status of his disease and its treatment, and to assist him in the&#xD;
      management of his disease on a daily basis (compliance, physical activity, nutrition, illness&#xD;
      experience... ) . This call will last approx. 15 minutes, however, the duration of the call&#xD;
      is not limited, but is defined according to the needs of the patient.&#xD;
&#xD;
      At the end of each call, the nurse will define with the patient educational goals (disease&#xD;
      knowledge, treatments, recognizing acute episodes symptoms, learning better health habits,&#xD;
      practise regular physical activity).&#xD;
&#xD;
      Cordiva center is also available for patient's inbound calls. In this way, patients will be&#xD;
      able to easily call the center during working hours, and discuss with a specialized Cordiva&#xD;
      nurse. This line is not an emergency line and does not replace the 112, which remains the&#xD;
      only accredited contact in case of emergencies.&#xD;
&#xD;
      In case of temporary travel of the patient away from home (i.e. for holidays), the patient&#xD;
      can take the box and scale with him. This material is provided with GPRS SIM card, so the&#xD;
      connection will be maintained. The patient may also provide an alternative phone number for&#xD;
      the calls with the nurses.&#xD;
&#xD;
      The patient's GP will be involved in this outpatient care from the beginning of the study.&#xD;
      Indeed, data collected through the connected boxes and scales will be displayed in dedicated&#xD;
      reports sent to the GP. These reports will be transmitted every 2 months. These reports will&#xD;
      also be sent to the referring cardiologist if requested.&#xD;
&#xD;
      Moreover, in case of validated alerts, the referring physician will have access to a weight&#xD;
      and symptoms report, allowing him to take any action he thinks appropriate.&#xD;
&#xD;
      ABOUT CORDIVA CENTER: The center has a team of specialized and graduated nurses in heart&#xD;
      failure management and in therapeutic education, due to the dedicated training they have&#xD;
      received. Indeed, many studies in the multidisciplinary care of heart failure patients have&#xD;
      demonstrated the key role of nurses, acting as bridge between patients and health&#xD;
      professionals.&#xD;
&#xD;
      The nurses take care of patient compliance based on the referring cardiologist or general&#xD;
      practitioner instructions, and monitor patient clinical parameters (weight and symptoms). The&#xD;
      nurses use a software based interviews guide. Patient objectives are defined based on&#xD;
      information regarding certain factors (health status, clinical signs, drugs), and this&#xD;
      information will be collected by the nurses into a computerized database. This information is&#xD;
      requested in strict patient accompanying perspective and therefore do not appear in the study&#xD;
      results.&#xD;
&#xD;
      The two data sets (data collected by nurses for patient management on one hand, and data&#xD;
      collected by CST for the study on another hand) will never be connected and only study data&#xD;
      from CST will be used to assess study criteria.&#xD;
&#xD;
      To evaluate patient knowledge and needs, the nurses use active listening (open questions,&#xD;
      paraphrasing, empathy and positive reinforcement). These techniques help them to customize&#xD;
      information and messages and reinforce personalized care. Cordiva center nurses benefit from&#xD;
      specialized training in motivational interviewing. They have also received dedicated training&#xD;
      in cardiology and heart failure, &quot;mental state&quot; of heart failure patients, communication and&#xD;
      patient education.&#xD;
&#xD;
      Coherence of this informative approach is guaranteed on one hand because of the tools&#xD;
      available for the nurses (binder, interview guide), and on the other hand because of the&#xD;
      center organization itself: monitoring of patients insured by team of nurses, weekly debrief&#xD;
      of recorded calls…&#xD;
&#xD;
      EXTENSION PERIOD:&#xD;
&#xD;
      The extension period will be conducted on an open, non-comparative basis. The aim of the&#xD;
      extension period is to allow patients who wish to do so to follow the telemonitoring program&#xD;
      until its marketing, regardless of the randomization group on initial inclusion in the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2013</start_date>
  <completion_date type="Actual">September 28, 2018</completion_date>
  <primary_completion_date type="Actual">December 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of All Causes Deaths and (Unplanned) Hospitalizations</measure>
    <time_frame>18 months</time_frame>
    <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients</measure>
    <time_frame>18 months</time_frame>
    <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients</measure>
    <time_frame>18 months</time_frame>
    <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to First Unplanned Hospital Readmission or Death From Any Cause</measure>
    <time_frame>18 months</time_frame>
    <description>Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All Causes Deaths - Number of Patients Who Died From Any Cause</measure>
    <time_frame>18 months</time_frame>
    <description>Number of patients who died from any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Death From Any Cause</measure>
    <time_frame>18 months</time_frame>
    <description>Time to death from any cause in the subgroup of patients who died</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Unplanned Hospitalizations for Any Cause</measure>
    <time_frame>18 months</time_frame>
    <description>Number of unplanned hospitalizations for any cause (adjudicated events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause</measure>
    <time_frame>18 months</time_frame>
    <description>Composite morbidity-mortality criterion combining the number of cardiovascular unplanned hospitalizations and deaths from cardiovascular cause (adjudicated events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Unplanned Hospitalizations for Heart Failure</measure>
    <time_frame>18 months</time_frame>
    <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients</measure>
    <time_frame>18 months</time_frame>
    <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients</measure>
    <time_frame>18 months</time_frame>
    <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Unplanned Hospital Readmission for Heart Failure</measure>
    <time_frame>18 months</time_frame>
    <description>Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores</measure>
    <time_frame>Between baseline and 12 months and between baseline and 18 months</time_frame>
    <description>Evolution of Quality of Life assessed using absolute changes from baseline of each dimension and both component summary scores of SF-36 questionnaire. Indeed, SF-36 questionnaire include 8 general dimensions and 2 composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). They are standardized to range between 0 and 100. Higher scores on all SF-36 scales indicate more favorable levels of functioning and less disability. Thus, higher Physical Functioning scores reflect higher physical functioning. Higher Role Physical scores reflect lower limitations due to physical problems. Higher Bodily Pain scores reflect less bodily pain. Higher General Health scores reflect higher general health perception. Higher Vitality scores reflect higher vitality. Higher Social Functioning scores reflect higher social functioning. Higher Role Emotional scores reflect lower limitations due to emotional problems. Higher Mental Health scores reflect better mental health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period</measure>
    <time_frame>Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)</time_frame>
    <description>Annualized number of unplanned hospitalizations for any cause according to investigators in patients hospitalized at least once during the extension period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Who Died From Any Cause During the Extension Period</measure>
    <time_frame>Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)</time_frame>
    <description>Number of patients who died from any cause during the extension period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period</measure>
    <time_frame>Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)</time_frame>
    <description>Annualized number of unplanned hospitalizations from cardiovascular cause according to investigators in patients hospitalized at least once for cardiovascular cause during the extension period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Who Died From Cardiovascular Cause During the Extension Period</measure>
    <time_frame>Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)</time_frame>
    <description>Number of patients who died from cardiovascular cause according to investigators during the extension period</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">990</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tele-cardiology group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Telecardiology Program</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telecardiology program</intervention_name>
    <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
    <arm_group_label>Tele-cardiology group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 years or older&#xD;
&#xD;
          -  Men or women patient with heart failure having been hospitalized for cardiac&#xD;
             decompensation during the last 12 months.&#xD;
&#xD;
          -  Patient with access to a wireline telephone service or GPRS network.&#xD;
&#xD;
          -  The patient is willing and able to sign an informed written consent&#xD;
&#xD;
          -  Patient is insured under the social security system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No available echocardiographic evaluation.&#xD;
&#xD;
          -  BNP lower than 100pg/ml or NT-proBNP lower than 300pg/ml&#xD;
&#xD;
          -  A prognosis of a life span of less than 12 months (apart from heart failure)&#xD;
&#xD;
          -  Dialysis patients&#xD;
&#xD;
          -  Heart transplant or cardiac assist devices&#xD;
&#xD;
          -  Patients involved in inotropic treatment&#xD;
&#xD;
          -  Patient doesn't have the necessary autonomy to use the equipment&#xD;
&#xD;
          -  Patient enrolled in another clinical trial&#xD;
&#xD;
          -  A pregnant or nursing woman, or patient of reproductive age who doesn't use&#xD;
             contraceptives&#xD;
&#xD;
          -  Patients under tutorship, curatorship or judicial protection&#xD;
&#xD;
        Inclusion Criteria in the extension period:&#xD;
&#xD;
        Participation in the open extension period is only offered to patients who participated in&#xD;
        the comparative period of the study, did not withdraw prematurely from the latter and gave&#xD;
        their free informed written consent to participate to the extension period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel GALINIER, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rangueil University Hospital - Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Atul PATHAK, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Pasteur</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cabinet de Cardiologie - Pôle médical spécialisé</name>
      <address>
        <city>Béziers</city>
        <state>Languedoc-Rousillon</state>
        <zip>34500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Béziers</name>
      <address>
        <city>Beziers</city>
        <state>Languedoc-Roussillon</state>
        <zip>34500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral</name>
      <address>
        <city>St Yrieix la Perche</city>
        <state>Limousin</state>
        <zip>87500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet libéral de Cardiologie du Muret</name>
      <address>
        <city>Muret</city>
        <state>Midi-pyrenées</state>
        <zip>31600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Général d'Auch</name>
      <address>
        <city>Auch</city>
        <state>Midi-Pyrénées</state>
        <zip>32008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de réadaptation cardiovasculaire Midi-Gascogne</name>
      <address>
        <city>Beaumont de Lomagne</city>
        <state>Midi-Pyrénées</state>
        <zip>82500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Cahors</name>
      <address>
        <city>Cahors</city>
        <state>Midi-Pyrénées</state>
        <zip>46000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal Castres-Mazamet</name>
      <address>
        <city>Castres</city>
        <state>Midi-Pyrénées</state>
        <zip>81108</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique des Cèdres</name>
      <address>
        <city>Cornebarrieu</city>
        <state>Midi-Pyrénées</state>
        <zip>31700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de l'Union et du Vaurais</name>
      <address>
        <city>L'Union</city>
        <state>Midi-Pyrénées</state>
        <zip>31240</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Pont de Chaume</name>
      <address>
        <city>Montauban</city>
        <state>Midi-Pyrénées</state>
        <zip>82000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Rodez</name>
      <address>
        <city>Rodez</city>
        <state>Midi-Pyrénées</state>
        <zip>12027</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal du Val d'Ariège</name>
      <address>
        <city>Saint-Jean-de-Verges</city>
        <state>Midi-Pyrénées</state>
        <zip>09000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique de l'Ormeau</name>
      <address>
        <city>Tarbes</city>
        <state>Midi-Pyrénées</state>
        <zip>65000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Toulouse - Hôpital de Rangueil</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Joseph Ducuing</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Amiens de Picardie</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Avignon - Hospital Henri Duffaut</name>
      <address>
        <city>Avignon</city>
        <zip>84090</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Bastia</name>
      <address>
        <city>Bastia</city>
        <zip>20604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Bordeaux - Hôpital Saint André</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Lyon - Hôpital Louis Pradel</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire François Mitterrand - Cardiologie 2 : Rythmologie et Insuffisance Cardiaque</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire François Mitterrand - Cardiologie Générale</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Léon Bérard</name>
      <address>
        <city>Hyères</city>
        <zip>83418</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Grenoble - Hôpital Antoine Michallon</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Marseille - Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nice - Hôpital Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Caremeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Pau</name>
      <address>
        <city>Pau</city>
        <zip>64420</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Bordeaux - Hôpital Haut Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Périgueux</name>
      <address>
        <city>Périgueux</city>
        <zip>24000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Toulon - La Seyne-sur-Mer</name>
      <address>
        <city>Toulon</city>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Martinique</name>
      <address>
        <city>Fort-de-France</city>
        <zip>97200</zip>
        <country>Martinique</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Martinique</country>
  </location_countries>
  <results_reference>
    <citation>Galinier M, Roubille F, Berdague P, Brierre G, Cantie P, Dary P, Ferradou JM, Fondard O, Labarre JP, Mansourati J, Picard F, Ricci JE, Salvat M, Tartière L, Ruidavets JB, Bongard V, Delval C, Lancman G, Pasche H, Ramirez-Gil JF, Pathak A; OSICAT Investigators. Telemonitoring versus standard care in heart failure: a randomised multicentre trial. Eur J Heart Fail. 2020 Jun;22(6):985-994. doi: 10.1002/ejhf.1906. Epub 2020 Jun 15.</citation>
    <PMID>32438483</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 17, 2014</study_first_submitted>
  <study_first_submitted_qc>February 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2014</study_first_posted>
  <results_first_submitted>June 28, 2021</results_first_submitted>
  <results_first_submitted_qc>September 28, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 26, 2021</results_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>E health</keyword>
  <keyword>Telemonitoring</keyword>
  <keyword>Prevention</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Cordiva</keyword>
  <keyword>Telecardiology Program</keyword>
  <keyword>Remote Patient Management</keyword>
  <keyword>Education</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 6, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT02068118/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 21, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT02068118/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between May 13, 2013 and June 22, 2016, 990 patients were enrolled at 38 French centers. Last patient completed 18-month comparative period on December 20, 2017. After this 18-month period, 20 patients entered the non-comparative extension period between June 1, 2017 and March 27, 2018. Last patient completed extension period on September 28, 2018.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Standard Care</title>
          <description>Period 1: Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists.&#xD;
Period 2: Patients on standard follow-up during Period 1 were equipped with the Telecardiology Program if they wished and consented to enter the extension period.</description>
        </group>
        <group group_id="P2">
          <title>Tele-cardiology Group</title>
          <description>Device: Telecardiology Program&#xD;
- Period 1: The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.&#xD;
- Period 2: Patients on Telecardiology Program during Period 1 were allowed to continue it until its marketing if they wished and consented to enter the extension period.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>18-month Comparative Study Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="455"/>
                <participants group_id="P2" count="482"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="327"/>
                <participants group_id="P2" count="305"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="128"/>
                <participants group_id="P2" count="177"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="90"/>
                <participants group_id="P2" count="97"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Heart transplant</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inclusion in another protocol</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Hemiplegia</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Alzheimer's disease</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Move</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Hearing loss</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Extension Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7">Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented</participants>
                <participants group_id="P2" count="13">Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Heart transplant</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Wrong device use</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>ITT population included all study patients randomized once, who left the hospital alive and continued their study participation after their home return and who were not included in the 2 study centers where investigators withdrew their participation.</population>
      <group_list>
        <group group_id="B1">
          <title>Standard Care</title>
          <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
        </group>
        <group group_id="B2">
          <title>Tele-cardiology Group</title>
          <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="455"/>
            <count group_id="B2" value="482"/>
            <count group_id="B3" value="937"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.7" spread="12.5"/>
                    <measurement group_id="B2" value="70.0" spread="12.4"/>
                    <measurement group_id="B3" value="69.9" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt; 60 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                    <measurement group_id="B2" value="93"/>
                    <measurement group_id="B3" value="198"/>
                  </measurement_list>
                </category>
                <category>
                  <title>≥ 60 and &lt; 80 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="237"/>
                    <measurement group_id="B2" value="268"/>
                    <measurement group_id="B3" value="505"/>
                  </measurement_list>
                </category>
                <category>
                  <title>≥ 80 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                    <measurement group_id="B2" value="121"/>
                    <measurement group_id="B3" value="234"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="132"/>
                    <measurement group_id="B2" value="128"/>
                    <measurement group_id="B3" value="260"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="323"/>
                    <measurement group_id="B2" value="354"/>
                    <measurement group_id="B3" value="677"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>France</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="455"/>
                    <measurement group_id="B2" value="482"/>
                    <measurement group_id="B3" value="937"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NYHA classification</title>
          <description>NYHA: New York Heart Association functional classification categories chronic heart failure patients in 4 stages based on how much they are limited during physical activity. Stage I corresponds to 'No limitation of physical activity', Stage II to 'Slight limitation of physical activity', Stage III to 'Marked limitation of physical activity' and Stage IV to 'Unable to carry on any physical activity without discomfort, symptoms of heart failure at rest</description>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="452"/>
                    <count group_id="B2" value="475"/>
                    <count group_id="B3" value="927"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="196"/>
                    <measurement group_id="B2" value="210"/>
                    <measurement group_id="B3" value="406"/>
                  </measurement_list>
                </category>
                <category>
                  <title>III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="185"/>
                    <measurement group_id="B2" value="182"/>
                    <measurement group_id="B3" value="367"/>
                  </measurement_list>
                </category>
                <category>
                  <title>IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiopathy</title>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="454"/>
                    <count group_id="B2" value="481"/>
                    <count group_id="B3" value="935"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Ischemic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="211"/>
                    <measurement group_id="B2" value="232"/>
                    <measurement group_id="B3" value="443"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Non Ischemic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="243"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="492"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart failure</title>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="453"/>
                    <count group_id="B2" value="480"/>
                    <count group_id="B3" value="933"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Left</title>
                  <measurement_list>
                    <measurement group_id="B1" value="184"/>
                    <measurement group_id="B2" value="185"/>
                    <measurement group_id="B3" value="369"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Right</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Global</title>
                  <measurement_list>
                    <measurement group_id="B1" value="235"/>
                    <measurement group_id="B2" value="271"/>
                    <measurement group_id="B3" value="506"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular Ejection Fraction (LVEF)</title>
          <description>Left ventricular ejection fraction refers to the percentage of blood that is pumped out of the filled left ventricle with each contraction of this ventricle. It is calculated on echocardiography mainly. It is the percentage corresponding to the ratio of heart stroke volume (which is the difference between end-diastolic volume and end-systolic volume) divided by end-diastolic volume.</description>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>Percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="479"/>
                    <count group_id="B3" value="934"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.1" spread="15.2"/>
                    <measurement group_id="B2" value="39.3" spread="14.5"/>
                    <measurement group_id="B3" value="38.7" spread="14.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular Ejection Fraction (LVEF), categorical</title>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="479"/>
                    <count group_id="B3" value="934"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>≤ 40%</title>
                  <measurement_list>
                    <measurement group_id="B1" value="280"/>
                    <measurement group_id="B2" value="280"/>
                    <measurement group_id="B3" value="560"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt; 40% and ≤ 50%</title>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="184"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt; 50%</title>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="104"/>
                    <measurement group_id="B3" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BNP</title>
          <description>BNP: B-type Natriuretic Peptide</description>
          <population>Difference from the overall number of baseline participants due to missing data and assay of either BNP or NT pro BNP for each participant.</population>
          <units>pg/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="191"/>
                    <count group_id="B2" value="211"/>
                    <count group_id="B3" value="402"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="484" lower_limit="301" upper_limit="929"/>
                    <measurement group_id="B2" value="510" lower_limit="303" upper_limit="900"/>
                    <measurement group_id="B3" value="501" lower_limit="303" upper_limit="911"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NT-pro-BNP</title>
          <description>N-Terminal-pro-B-type Natriuretic Peptide</description>
          <population>Difference from the overall number of baseline participants due to missing data and assay of either NT pro BNP or BNP for each participant.</population>
          <units>pg/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="265"/>
                    <count group_id="B2" value="269"/>
                    <count group_id="B3" value="534"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3277" lower_limit="1666" upper_limit="6914"/>
                    <measurement group_id="B2" value="3519" lower_limit="1778" upper_limit="6553"/>
                    <measurement group_id="B3" value="3379" lower_limit="1732" upper_limit="6694"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous participation in an ETP</title>
          <description>ETP= Educational Therapeutic Program</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="114"/>
                    <measurement group_id="B2" value="109"/>
                    <measurement group_id="B3" value="223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="341"/>
                    <measurement group_id="B2" value="373"/>
                    <measurement group_id="B3" value="714"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Arterial hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="246"/>
                    <measurement group_id="B2" value="296"/>
                    <measurement group_id="B3" value="542"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="209"/>
                    <measurement group_id="B2" value="186"/>
                    <measurement group_id="B3" value="395"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dyslipidemia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="248"/>
                    <measurement group_id="B2" value="269"/>
                    <measurement group_id="B3" value="517"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="207"/>
                    <measurement group_id="B2" value="213"/>
                    <measurement group_id="B3" value="420"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Family History of Cardiovascular Disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                    <measurement group_id="B2" value="109"/>
                    <measurement group_id="B3" value="182"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="382"/>
                    <measurement group_id="B2" value="373"/>
                    <measurement group_id="B3" value="755"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Obesity</title>
          <description>Obesity defined as Body Mass Index (BMI) ≥ 30.0 kg/m²</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="122"/>
                    <measurement group_id="B2" value="140"/>
                    <measurement group_id="B3" value="262"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="333"/>
                    <measurement group_id="B2" value="342"/>
                    <measurement group_id="B3" value="675"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="116"/>
                    <measurement group_id="B2" value="111"/>
                    <measurement group_id="B3" value="227"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="339"/>
                    <measurement group_id="B2" value="371"/>
                    <measurement group_id="B3" value="710"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Coronary heart disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="228"/>
                    <measurement group_id="B2" value="236"/>
                    <measurement group_id="B3" value="464"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="227"/>
                    <measurement group_id="B2" value="246"/>
                    <measurement group_id="B3" value="473"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes mellitus</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="161"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="307"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="294"/>
                    <measurement group_id="B2" value="336"/>
                    <measurement group_id="B3" value="630"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic renal disease</title>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="481"/>
                    <count group_id="B3" value="936"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="128"/>
                    <measurement group_id="B2" value="129"/>
                    <measurement group_id="B3" value="257"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="327"/>
                    <measurement group_id="B2" value="352"/>
                    <measurement group_id="B3" value="679"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic Obstructive Pulmonary Disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="178"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="366"/>
                    <measurement group_id="B2" value="393"/>
                    <measurement group_id="B3" value="759"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Implantable cardioverter-defibrillator</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="395"/>
                    <measurement group_id="B2" value="422"/>
                    <measurement group_id="B3" value="817"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiac resynchronization therapy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="454"/>
                    <measurement group_id="B2" value="482"/>
                    <measurement group_id="B3" value="936"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Loop diuretics</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="417"/>
                    <measurement group_id="B2" value="447"/>
                    <measurement group_id="B3" value="864"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beta-blockers</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="367"/>
                    <measurement group_id="B2" value="379"/>
                    <measurement group_id="B3" value="746"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="88"/>
                    <measurement group_id="B2" value="103"/>
                    <measurement group_id="B3" value="191"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ACE inhibitors or ARBs</title>
          <description>ACE: Angiotensin-Converting Enzyme; ARB: Angiotensin II Receptor Blocker</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="345"/>
                    <measurement group_id="B2" value="354"/>
                    <measurement group_id="B3" value="699"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                    <measurement group_id="B2" value="128"/>
                    <measurement group_id="B3" value="238"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Aldosterone antagonists</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="211"/>
                    <measurement group_id="B2" value="220"/>
                    <measurement group_id="B3" value="431"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="244"/>
                    <measurement group_id="B2" value="262"/>
                    <measurement group_id="B3" value="506"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ivabradine</title>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="453"/>
                    <count group_id="B2" value="479"/>
                    <count group_id="B3" value="932"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="416"/>
                    <measurement group_id="B2" value="456"/>
                    <measurement group_id="B3" value="872"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Digoxin</title>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="454"/>
                    <count group_id="B2" value="481"/>
                    <count group_id="B3" value="935"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="439"/>
                    <measurement group_id="B2" value="453"/>
                    <measurement group_id="B3" value="892"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glomerular Filtration Rate (GFR)</title>
          <description>Glomerular Filtration Rate estimated using Modification of Diet in Renal Disease (MDRD) formula</description>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="478"/>
                    <count group_id="B3" value="933"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.6" spread="25.1"/>
                    <measurement group_id="B2" value="60.5" spread="25.5"/>
                    <measurement group_id="B3" value="60.5" spread="25.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77.2" spread="17.8"/>
                    <measurement group_id="B2" value="79.3" spread="18.2"/>
                    <measurement group_id="B3" value="78.3" spread="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m²</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.1" spread="5.5"/>
                    <measurement group_id="B2" value="27.6" spread="6.0"/>
                    <measurement group_id="B3" value="27.4" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Supine systolic blood pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="118.9" spread="19.3"/>
                    <measurement group_id="B2" value="119.6" spread="19.9"/>
                    <measurement group_id="B3" value="119.3" spread="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Supine diastolic blood pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="482"/>
                    <count group_id="B3" value="937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.5" spread="12.2"/>
                    <measurement group_id="B2" value="69.9" spread="11.2"/>
                    <measurement group_id="B3" value="69.7" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Supine pulse rate</title>
          <population>Difference from the overall number of baseline participants due to missing data.</population>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="455"/>
                    <count group_id="B2" value="481"/>
                    <count group_id="B3" value="936"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.7" spread="13.9"/>
                    <measurement group_id="B2" value="73.7" spread="15.4"/>
                    <measurement group_id="B3" value="73.2" spread="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of All Causes Deaths and (Unplanned) Hospitalizations</title>
        <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
        <time_frame>18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of All Causes Deaths and (Unplanned) Hospitalizations</title>
          <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
          <population>ITT population</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="455"/>
                <count group_id="O2" value="482"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.46" spread="1.98"/>
                    <measurement group_id="O2" value="1.30" spread="1.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).&#xD;
Deaths that occurred during hospitalization with an overnight stay were counted as two events.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.80</p_value>
            <method>negative binomial regression</method>
            <param_type>rate ratio</param_type>
            <param_value>0.97</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.77</ci_lower_limit>
            <ci_upper_limit>1.23</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients</title>
        <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
        <time_frame>18 months</time_frame>
        <population>ITT population with New York Heart Association (NYHA) class III or IV at inclusion (N=460 patients)</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients</title>
          <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
          <population>ITT population with New York Heart Association (NYHA) class III or IV at inclusion (N=460 patients)</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="224"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.99" spread="2.26"/>
                    <measurement group_id="O2" value="1.53" spread="1.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).&#xD;
Deaths that occurred during hospitalization with an overnight stay were counted as two events.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.18</p_value>
            <method>negative binomial regression</method>
            <param_type>rate ratio</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients</title>
        <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
        <time_frame>18 months</time_frame>
        <population>ITT population with socially isolated status at inclusion (N=216 patients) defined as: either i) SF-36 Mental Health score &lt;45; or ii) Mental Component Summary score &lt;35; or iii) combination of Mental Health score &lt;50 plus Mental Component Summary score &lt;40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients</title>
          <description>Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)</description>
          <population>ITT population with socially isolated status at inclusion (N=216 patients) defined as: either i) SF-36 Mental Health score &lt;45; or ii) Mental Component Summary score &lt;35; or iii) combination of Mental Health score &lt;50 plus Mental Component Summary score &lt;40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="112"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.89" spread="2.14"/>
                    <measurement group_id="O2" value="1.30" spread="1.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).&#xD;
Deaths that occurred during hospitalization with an overnight stay were counted as two events.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.02</p_value>
            <method>negative binomial regression</method>
            <param_type>rate ratio</param_type>
            <param_value>0.60</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.39</ci_lower_limit>
            <ci_upper_limit>0.92</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Unplanned Hospital Readmission or Death From Any Cause</title>
        <description>Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned</description>
        <time_frame>18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Unplanned Hospital Readmission or Death From Any Cause</title>
          <description>Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned</description>
          <population>ITT population</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="254"/>
                <count group_id="O2" value="255"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" lower_limit="29" upper_limit="238"/>
                    <measurement group_id="O2" value="105" lower_limit="30" upper_limit="232"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time to first event compared using the log-rank test</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.68</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Causes Deaths - Number of Patients Who Died From Any Cause</title>
        <description>Number of patients who died from any cause</description>
        <time_frame>18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>All Causes Deaths - Number of Patients Who Died From Any Cause</title>
          <description>Number of patients who died from any cause</description>
          <population>ITT population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="455"/>
                <count group_id="O2" value="482"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Death From Any Cause</title>
        <description>Time to death from any cause in the subgroup of patients who died</description>
        <time_frame>18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Death From Any Cause</title>
          <description>Time to death from any cause in the subgroup of patients who died</description>
          <population>ITT population</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="89"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="233" lower_limit="100" upper_limit="390"/>
                    <measurement group_id="O2" value="252" lower_limit="148" upper_limit="369"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time to death from any cause compared using the log-rank test</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.85</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Unplanned Hospitalizations for Any Cause</title>
        <description>Number of unplanned hospitalizations for any cause (adjudicated events)</description>
        <time_frame>18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Unplanned Hospitalizations for Any Cause</title>
          <description>Number of unplanned hospitalizations for any cause (adjudicated events)</description>
          <population>ITT population</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="455"/>
                <count group_id="O2" value="482"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.27" spread="1.82"/>
                    <measurement group_id="O2" value="1.11" spread="1.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.77</p_value>
            <method>negative binomial regression</method>
            <param_type>rate ratio</param_type>
            <param_value>0.97</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.78</ci_lower_limit>
            <ci_upper_limit>1.21</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause</title>
        <description>Composite morbidity-mortality criterion combining the number of cardiovascular unplanned hospitalizations and deaths from cardiovascular cause (adjudicated events)</description>
        <time_frame>18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause</title>
          <description>Composite morbidity-mortality criterion combining the number of cardiovascular unplanned hospitalizations and deaths from cardiovascular cause (adjudicated events)</description>
          <population>ITT population</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="455"/>
                <count group_id="O2" value="482"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="1.75"/>
                    <measurement group_id="O2" value="0.96" spread="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).&#xD;
Deaths from cardiovascular cause that occurred during a hospitalization for cardiovascular cause with an overnight stay were counted as two events.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.83</p_value>
            <method>negative binomial regression</method>
            <param_type>rate ratio</param_type>
            <param_value>0.97</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>1.27</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Unplanned Hospitalizations for Heart Failure</title>
        <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
        <time_frame>18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Unplanned Hospitalizations for Heart Failure</title>
          <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
          <population>ITT population</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="455"/>
                <count group_id="O2" value="482"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" spread="1.42"/>
                    <measurement group_id="O2" value="0.59" spread="1.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.28</p_value>
            <method>negative binomial regression</method>
            <param_type>rate ratio</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>1.15</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients</title>
        <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
        <time_frame>18 months</time_frame>
        <population>ITT population with New York Heart Association (NYHA) class III or IV at inclusion (N=460 patients)</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients</title>
          <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
          <population>ITT population with New York Heart Association (NYHA) class III or IV at inclusion (N=460 patients)</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="224"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.02" spread="1.68"/>
                    <measurement group_id="O2" value="0.70" spread="1.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.078</p_value>
            <method>negative binomial regression</method>
            <param_type>rate ratio</param_type>
            <param_value>0.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.48</ci_lower_limit>
            <ci_upper_limit>1.04</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients</title>
        <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
        <time_frame>18 months</time_frame>
        <population>ITT population with socially isolated status at inclusion (N=216 patients) defined as: either i) SF-36 Mental Health score &lt;45; or ii) Mental Component Summary score &lt;35; or iii) combination of Mental Health score &lt;50 plus Mental Component Summary score &lt;40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients</title>
          <description>Number of unplanned hospitalizations for heart failure (adjudicated events)</description>
          <population>ITT population with socially isolated status at inclusion (N=216 patients) defined as: either i) SF-36 Mental Health score &lt;45; or ii) Mental Component Summary score &lt;35; or iii) combination of Mental Health score &lt;50 plus Mental Component Summary score &lt;40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="112"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" spread="1.61"/>
                    <measurement group_id="O2" value="0.58" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.023</p_value>
            <method>negative binomial regression</method>
            <param_type>rate ratio</param_type>
            <param_value>0.50</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.28</ci_lower_limit>
            <ci_upper_limit>0.91</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Unplanned Hospital Readmission for Heart Failure</title>
        <description>Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned</description>
        <time_frame>18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Unplanned Hospital Readmission for Heart Failure</title>
          <description>Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned</description>
          <population>ITT population</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="160"/>
                <count group_id="O2" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="28" upper_limit="236"/>
                    <measurement group_id="O2" value="97" lower_limit="32" upper_limit="252"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time to first unplanned hospital readmission for heart failure compared using multivariable Cox regression model</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.044</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores</title>
        <description>Evolution of Quality of Life assessed using absolute changes from baseline of each dimension and both component summary scores of SF-36 questionnaire. Indeed, SF-36 questionnaire include 8 general dimensions and 2 composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). They are standardized to range between 0 and 100. Higher scores on all SF-36 scales indicate more favorable levels of functioning and less disability. Thus, higher Physical Functioning scores reflect higher physical functioning. Higher Role Physical scores reflect lower limitations due to physical problems. Higher Bodily Pain scores reflect less bodily pain. Higher General Health scores reflect higher general health perception. Higher Vitality scores reflect higher vitality. Higher Social Functioning scores reflect higher social functioning. Higher Role Emotional scores reflect lower limitations due to emotional problems. Higher Mental Health scores reflect better mental health.</description>
        <time_frame>Between baseline and 12 months and between baseline and 18 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores</title>
          <description>Evolution of Quality of Life assessed using absolute changes from baseline of each dimension and both component summary scores of SF-36 questionnaire. Indeed, SF-36 questionnaire include 8 general dimensions and 2 composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). They are standardized to range between 0 and 100. Higher scores on all SF-36 scales indicate more favorable levels of functioning and less disability. Thus, higher Physical Functioning scores reflect higher physical functioning. Higher Role Physical scores reflect lower limitations due to physical problems. Higher Bodily Pain scores reflect less bodily pain. Higher General Health scores reflect higher general health perception. Higher Vitality scores reflect higher vitality. Higher Social Functioning scores reflect higher social functioning. Higher Role Emotional scores reflect lower limitations due to emotional problems. Higher Mental Health scores reflect better mental health.</description>
          <population>ITT population</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="323"/>
                <count group_id="O2" value="307"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physical Functioning - 12 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="323"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="27.3"/>
                    <measurement group_id="O2" value="0.0" spread="28.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Functioning - 18 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="303"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="26.3"/>
                    <measurement group_id="O2" value="1.3" spread="28.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Physical - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="322"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" spread="48.0"/>
                    <measurement group_id="O2" value="12.5" spread="48.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Physical - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="303"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.5" spread="40.2"/>
                    <measurement group_id="O2" value="20.7" spread="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily Pain - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="322"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="38.8"/>
                    <measurement group_id="O2" value="4.1" spread="36.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily Pain - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="303"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="35.8"/>
                    <measurement group_id="O2" value="4.6" spread="33.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General Health - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="321"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="21.7"/>
                    <measurement group_id="O2" value="3.4" spread="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General Health - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="303"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="20.4"/>
                    <measurement group_id="O2" value="6.8" spread="22.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="322"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="22.1"/>
                    <measurement group_id="O2" value="9.0" spread="23.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="303"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" spread="21.7"/>
                    <measurement group_id="O2" value="11.1" spread="21.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Functioning - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="321"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="35.5"/>
                    <measurement group_id="O2" value="4.4" spread="33.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Functioning - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="303"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="33.3"/>
                    <measurement group_id="O2" value="3.8" spread="33.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Emotional - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="322"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.3" spread="45.7"/>
                    <measurement group_id="O2" value="-2.7" spread="46.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Emotional - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="302"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="35.8"/>
                    <measurement group_id="O2" value="8.3" spread="35.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Health - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="321"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="19.4"/>
                    <measurement group_id="O2" value="3.9" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Health - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="303"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="18.9"/>
                    <measurement group_id="O2" value="4.3" spread="18.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Component Summary - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="321"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="11.2"/>
                    <measurement group_id="O2" value="2.2" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Component Summary - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="302"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="10.6"/>
                    <measurement group_id="O2" value="3.2" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Component Summary - 12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="321"/>
                    <count group_id="O2" value="307"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="10.8"/>
                    <measurement group_id="O2" value="1.8" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Component Summary - 18 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="302"/>
                    <count group_id="O2" value="284"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="10.4"/>
                    <measurement group_id="O2" value="3.1" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Physical Functioning score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with physical functioning score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.17</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>1.06</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.48</ci_lower_limit>
            <ci_upper_limit>4.61</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Role Physical score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with role physical score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.23</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>1.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.61</ci_lower_limit>
            <ci_upper_limit>6.21</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Bodily Pain score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with bodily pain score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.50</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>4.46</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.59</ci_lower_limit>
            <ci_upper_limit>8.33</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA General Health score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with general health score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.19</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>2.52</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.07</ci_lower_limit>
            <ci_upper_limit>5.12</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Vitality score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with vitality score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.034</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>2.38</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.09</ci_lower_limit>
            <ci_upper_limit>4.85</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Social Functioning score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with social functioning score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.025</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>4.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.60</ci_lower_limit>
            <ci_upper_limit>7.47</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Role Emotional score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with role emotional score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.90</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>1.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.79</ci_lower_limit>
            <ci_upper_limit>4.81</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Mental Health score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with mental health score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.19</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>2.26</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.16</ci_lower_limit>
            <ci_upper_limit>4.37</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Physical Component Summary (PCS) score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with PCS score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.26</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.48</ci_lower_limit>
            <ci_upper_limit>2.28</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA Mental Component Summary (MCS) score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with MCS score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factor</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.17</p_value>
            <p_value_desc>Study group effect over time</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Adjusted Means Difference</param_type>
            <param_value>1.20</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.08</ci_lower_limit>
            <ci_upper_limit>2.31</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period</title>
        <description>Annualized number of unplanned hospitalizations for any cause according to investigators in patients hospitalized at least once during the extension period</description>
        <time_frame>Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)</time_frame>
        <population>Extension Period Set</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care/Tele-cardiology</title>
            <description>Period 1: Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists.&#xD;
Period 2: Patients on standard follow-up during Period 1 were equipped with the Telecardiology Program if they wished and consented to enter the extension period.</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology/Tele-cardiology</title>
            <description>- Period 1: The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.&#xD;
- Period 2: Patients on Telecardiology Program during Period 1 were allowed to continue it until its marketing if they wished and consented to enter the extension period.</description>
          </group>
        </group_list>
        <measure>
          <title>Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period</title>
          <description>Annualized number of unplanned hospitalizations for any cause according to investigators in patients hospitalized at least once during the extension period</description>
          <population>Extension Period Set</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.30" spread="0.57"/>
                    <measurement group_id="O2" value="3.30" spread="2.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Who Died From Any Cause During the Extension Period</title>
        <description>Number of patients who died from any cause during the extension period</description>
        <time_frame>Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)</time_frame>
        <population>Extension Period Set</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care/Tele-cardiology</title>
            <description>Period 1: Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists.&#xD;
Period 2: Patients on standard follow-up during Period 1 were equipped with the Telecardiology Program if they wished and consented to enter the extension period.</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology/Tele-cardiology</title>
            <description>- Period 1: The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.&#xD;
- Period 2: Patients on Telecardiology Program during Period 1 were allowed to continue it until its marketing if they wished and consented to enter the extension period.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Who Died From Any Cause During the Extension Period</title>
          <description>Number of patients who died from any cause during the extension period</description>
          <population>Extension Period Set</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period</title>
        <description>Annualized number of unplanned hospitalizations from cardiovascular cause according to investigators in patients hospitalized at least once for cardiovascular cause during the extension period</description>
        <time_frame>Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)</time_frame>
        <population>Extension Period Set</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care/Tele-cardiology</title>
            <description>Period 1: Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists.&#xD;
Period 2: Patients on standard follow-up during Period 1 were equipped with the Telecardiology Program if they wished and consented to enter the extension period.</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology/Tele-cardiology</title>
            <description>- Period 1: The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.&#xD;
- Period 2: Patients on Telecardiology Program during Period 1 were allowed to continue it until its marketing if they wished and consented to enter the extension period.</description>
          </group>
        </group_list>
        <measure>
          <title>Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period</title>
          <description>Annualized number of unplanned hospitalizations from cardiovascular cause according to investigators in patients hospitalized at least once for cardiovascular cause during the extension period</description>
          <population>Extension Period Set</population>
          <units>Events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.30" spread="0.57"/>
                    <measurement group_id="O2" value="2.84" spread="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Who Died From Cardiovascular Cause During the Extension Period</title>
        <description>Number of patients who died from cardiovascular cause according to investigators during the extension period</description>
        <time_frame>Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)</time_frame>
        <population>Extension Period Set</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care/Tele-cardiology</title>
            <description>Period 1: Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists.&#xD;
Period 2: Patients on standard follow-up during Period 1 were equipped with the Telecardiology Program if they wished and consented to enter the extension period.</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology/Tele-cardiology</title>
            <description>- Period 1: The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.&#xD;
- Period 2: Patients on Telecardiology Program during Period 1 were allowed to continue it until its marketing if they wished and consented to enter the extension period.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Who Died From Cardiovascular Cause During the Extension Period</title>
          <description>Number of patients who died from cardiovascular cause according to investigators during the extension period</description>
          <population>Extension Period Set</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Time to First Unplanned Hospital Readmission or Death From Any Cause in NYHA Class III or IV Patients</title>
        <description>Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned</description>
        <time_frame>18 months</time_frame>
        <population>New York Heart Association (NYHA) class III or IV at inclusion patients with unplanned hospital readmission or death from any cause included in the Overall Number of Participants Analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Unplanned Hospital Readmission or Death From Any Cause in NYHA Class III or IV Patients</title>
          <description>Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned</description>
          <population>New York Heart Association (NYHA) class III or IV at inclusion patients with unplanned hospital readmission or death from any cause included in the Overall Number of Participants Analyzed</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="157"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67" lower_limit="27" upper_limit="191"/>
                    <measurement group_id="O2" value="82" lower_limit="29" upper_limit="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time to first event compared using the log-rank test</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.03</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Time to First Unplanned Hospital Readmission or Death From Any Cause in Socially Isolated Patients</title>
        <description>Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned</description>
        <time_frame>18 months</time_frame>
        <population>Patients with socially isolated status at inclusion defined as: either i) SF-36 Mental Health score &lt;45; or ii) Mental Component Summary score &lt;35; or iii) combination of Mental Health score &lt;50 plus Mental Component Summary score &lt;40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications and with unplanned hospital readmission or death from any cause included in the Overall Number of Participants Analyzed'</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Unplanned Hospital Readmission or Death From Any Cause in Socially Isolated Patients</title>
          <description>Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned</description>
          <population>Patients with socially isolated status at inclusion defined as: either i) SF-36 Mental Health score &lt;45; or ii) Mental Component Summary score &lt;35; or iii) combination of Mental Health score &lt;50 plus Mental Component Summary score &lt;40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications and with unplanned hospital readmission or death from any cause included in the Overall Number of Participants Analyzed'</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="28" upper_limit="240"/>
                    <measurement group_id="O2" value="91" lower_limit="32" upper_limit="277"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time to first event compared using the log-rank test</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.15</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Time to First Unplanned Hospital Readmission for Heart Failure in NYHA Class III or IV Patients</title>
        <description>Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned</description>
        <time_frame>18 months</time_frame>
        <population>New York Heart Association (NYHA) class III or IV at inclusion patients with unplanned hospital readmission for heart failure included in the Overall Number of Participants Analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Unplanned Hospital Readmission for Heart Failure in NYHA Class III or IV Patients</title>
          <description>Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned</description>
          <population>New York Heart Association (NYHA) class III or IV at inclusion patients with unplanned hospital readmission for heart failure included in the Overall Number of Participants Analyzed</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" lower_limit="24" upper_limit="182"/>
                    <measurement group_id="O2" value="82" lower_limit="30" upper_limit="183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time to first unplanned hospital readmission for heart failure compared using multivariable Cox regression model</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.02</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.53</ci_lower_limit>
            <ci_upper_limit>0.95</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Time to First Unplanned Hospital Readmission for Heart Failure in Socially Isolated Patients</title>
        <description>Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned</description>
        <time_frame>18 months</time_frame>
        <population>Patients with socially isolated status at inclusion defined as: either i) SF-36 Mental Health score &lt;45; or ii) Mental Component Summary score &lt;35; or iii) combination of Mental Health score &lt;50 plus Mental Component Summary score &lt;40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications and with unplanned hospital readmission for heart failure included in the Overall Number of Participants Analyzed'</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists</description>
          </group>
          <group group_id="O2">
            <title>Tele-cardiology Group</title>
            <description>The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Unplanned Hospital Readmission for Heart Failure in Socially Isolated Patients</title>
          <description>Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned</description>
          <population>Patients with socially isolated status at inclusion defined as: either i) SF-36 Mental Health score &lt;45; or ii) Mental Component Summary score &lt;35; or iii) combination of Mental Health score &lt;50 plus Mental Component Summary score &lt;40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications and with unplanned hospital readmission for heart failure included in the Overall Number of Participants Analyzed'</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77" lower_limit="27" upper_limit="231"/>
                    <measurement group_id="O2" value="80" lower_limit="23" upper_limit="318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time to first unplanned hospital readmission for heart failure compared using multivariable Cox regression model</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.043</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.62</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.39</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During their study participation, patients were only examined once by the investigating cardiologists at the study centers, at the time of their enrolment and randomization. After this Inclusion Visit, patients were followed up via four telephone calls, conducted by clinical study technicians (at 15 days, 6, 12 and 18 months, all ±15 days).</time_frame>
      <desc>Serious and Other [Not Including Serious] Adverse Events were not monitored/assessed in this study which did not involve any investigational medicinal product.&#xD;
Deaths and hospitalizations constituted the study outcome measures and efficacy criteria. Therefore, they were not considered a result from an Adverse Event and were not reported as Serious Adverse Events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard Care/Tele-cardiology</title>
          <description>Period 1: Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists.&#xD;
Period 2: Patients on standard follow-up during Period 1 were equipped with the Telecardiology Program if they wished and consented to enter the extension period.</description>
        </group>
        <group group_id="E2">
          <title>Tele-cardiology Group/Tele-cardiology</title>
          <description>- Period 1: The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses.&#xD;
Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.&#xD;
- Period 2: Patients on Telecardiology Program during Period 1 were allowed to continue it until its marketing if they wished and consented to enter the extension period.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="90" subjects_at_risk="455"/>
                <counts group_id="E2" subjects_affected="99" subjects_at_risk="482"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release, can require changes to the communication and can embargo communications regarding trial results for a period that is less than or equal to 180 days from the time submitted to the sponsor for review. The modifications made by the sponsor cannot in any way affect the scientific value of the publication.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There is no significant methodological limitation in this study.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Clinical Development Physician</name_or_title>
      <organization>CDM e-Health</organization>
      <phone>33 (0) 1 39 07 62 86</phone>
      <email>fralsi-ctpublication@airliquide.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

